Export
The link always opens the latest version of this page.
Ask an AI about it
Open in ChatGPTA new chat that reads this entry from the site Open in ClaudeThe same, in ClaudeShare the link instead of a file, and they will always see the latest version.
Files are a snapshot of today. The live page has anything newer.
GLP-1 receptor agonists
GLP-1 receptor agonists are compounds that activate glucagon-like peptide-1 receptors, developed within the biotech field and currently at commercial maturity 1.
Clinical Applications
These agents are established treatments for type 2 diabetes and weight loss 2. Emerging research suggests they may reduce the risk of serious infections, including tuberculosis, in type 2 diabetes patients, though this evidence remains preliminary 3. Potential applications in weight management and anti-aging have been proposed, but these remain speculative 4.
Facts 3
| Attribute | Value | Confidence | Sources | Cited |
|---|---|---|---|---|
| Field | biotech | low | 1 | 1 |
| Nature | compound | low | 1 | 1 |
| Maturity | commercial | low | 1 | 1 |
Applications 3
- May reduce risk of serious infections including tuberculosis in type 2 diabetes patients
- diabetes treatment, weight management, potential anti-aging
- diabetes treatment and weight loss
Frequently mentioned together 8
Sources 8
- Yo-yo dieting takes on a new shape in the age of Ozempic · New Atlas
- video How Food Choices Shape Memory, Cognition & Cravings | Dr. Scott Kanoski · Huberman Lab
- GLP-1s are being linked to fewer serious infections, including TB · Hacker News (YC)
- Are GLP-1 Drugs a ‘Fountain of Youth’? Doctors Explain Health Benefits Beyond Weight Loss - TODAY.com · Google News: Hacking
- How Demand for GLP-1s Overwhelmed the Global Drug System · Council on Foreign Relations
5 of 8 sources shown · Pro unlocks the full list